30 October 2026 Quarterly activities report for period ended 30 September 2026 Highlights: • Pilot Facility pathway refined to a single Company-controlled facility in Western Australia, providing a shorter and less capital-intensive route to commercial partnering • Engineering capability...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix is reading this filing.
Earlier from Nanollose
- Appendix 4E & Annual Report to shareholders
- Half Yearly Report and Accounts
- Andrew Moullin Appointed as MD/CEO
- Entitlement Issue Prospectus
- Strategic $2.1M Capital Raising
